411 related articles for article (PubMed ID: 32858889)
1. New Insights into the Role of Sphingolipid Metabolism in Melanoma.
Carrié L; Virazels M; Dufau C; Montfort A; Levade T; Ségui B; Andrieu-Abadie N
Cells; 2020 Aug; 9(9):. PubMed ID: 32858889
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine metabolism as a therapeutic target in cutaneous melanoma.
Dany M
Transl Res; 2017 Jul; 185():1-12. PubMed ID: 28528915
[TBL] [Abstract][Full Text] [Related]
3. Sphingolipid metabolism in the development and progression of cancer: one cancer's help is another's hindrance.
Piazzesi A; Afsar SY; van Echten-Deckert G
Mol Oncol; 2021 Dec; 15(12):3256-3279. PubMed ID: 34289244
[TBL] [Abstract][Full Text] [Related]
4. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
[TBL] [Abstract][Full Text] [Related]
5. Treatment Following Progression in Metastatic Melanoma: the State of the Art from Scientific Literature to Clinical Need.
Serra F; Barruscotti S; Dominioni T; Zuccarini A; Pedrazzoli P; Chiellino S
Curr Oncol Rep; 2021 May; 23(7):84. PubMed ID: 34009481
[TBL] [Abstract][Full Text] [Related]
6. The Critical Impact of Sphingolipid Metabolism in Breast Cancer Progression and Drug Response.
Corsetto PA; Zava S; Rizzo AM; Colombo I
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768427
[TBL] [Abstract][Full Text] [Related]
7. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
8. The Role of Sphingolipids in Cancer Immunotherapy.
Giussani P; Prinetti A; Tringali C
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204326
[TBL] [Abstract][Full Text] [Related]
9. Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials.
Beckham TH; Elojeimy S; Cheng JC; Turner LS; Hoffman SR; Norris JS; Liu X
Expert Opin Ther Targets; 2010 May; 14(5):529-39. PubMed ID: 20334489
[TBL] [Abstract][Full Text] [Related]
10. Cancer treatment strategies targeting sphingolipid metabolism.
Oskouian B; Saba JD
Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
[TBL] [Abstract][Full Text] [Related]
11. Sphingolipid/Ceramide Pathways and Autophagy in the Onset and Progression of Melanoma: Novel Therapeutic Targets and Opportunities.
Lai M; La Rocca V; Amato R; Freer G; Pistello M
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336922
[TBL] [Abstract][Full Text] [Related]
12. Interdiction of Sphingolipid Metabolism Revisited: Focus on Prostate Cancer.
Voelkel-Johnson C; Norris JS; White-Gilbertson S
Adv Cancer Res; 2018; 140():265-293. PubMed ID: 30060812
[TBL] [Abstract][Full Text] [Related]
13. New drug targets in metastatic melanoma.
Homet B; Ribas A
J Pathol; 2014 Jan; 232(2):134-41. PubMed ID: 24027077
[TBL] [Abstract][Full Text] [Related]
14. Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.
Shaw J; Costa-Pinheiro P; Patterson L; Drews K; Spiegel S; Kester M
Adv Cancer Res; 2018; 140():327-366. PubMed ID: 30060815
[TBL] [Abstract][Full Text] [Related]
15. Acid Ceramidase in Melanoma: EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION.
Realini N; Palese F; Pizzirani D; Pontis S; Basit A; Bach A; Ganesan A; Piomelli D
J Biol Chem; 2016 Jan; 291(5):2422-34. PubMed ID: 26553872
[TBL] [Abstract][Full Text] [Related]
16. Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives.
Marra A; Ferrone CR; Fusciello C; Scognamiglio G; Ferrone S; Pepe S; Perri F; Sabbatino F
Anticancer Agents Med Chem; 2018; 18(2):166-181. PubMed ID: 29256359
[TBL] [Abstract][Full Text] [Related]
17. Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa.
Dany M; Elston D
J Am Acad Dermatol; 2017 Aug; 77(2):268-273.e6. PubMed ID: 28551069
[TBL] [Abstract][Full Text] [Related]
18. A novel jaspine B-ceramide hybrid modulates sphingolipid metabolism.
Garcia V; Le Faouder P; Dupuy A; Levade T; Ballereau S; Génisson Y
Chem Biodivers; 2015 Jul; 12(7):1115-25. PubMed ID: 26172331
[TBL] [Abstract][Full Text] [Related]
19. Effects of sphingolipid metabolism disorders on endothelial cells.
Lai Y; Tian Y; You X; Du J; Huang J
Lipids Health Dis; 2022 Oct; 21(1):101. PubMed ID: 36229882
[TBL] [Abstract][Full Text] [Related]
20. β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism.
Belleri M; Paganini G; Coltrini D; Ronca R; Zizioli D; Corsini M; Barbieri A; Grillo E; Calza S; Bresciani R; Maiorano E; Mastropasqua MG; Annese T; Giacomini A; Ribatti D; Casas J; Levade T; Fabrias G; Presta M
Cancer Res; 2020 Nov; 80(22):5011-5023. PubMed ID: 32998995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]